MDMAPharmala Biotech HoldingsMDMA info
$0.07info-5.26%24h
Global rank34260
Market cap$5.60M
Change 7d28.57%
YTD Performance-37.93%
SP500 benchmarkUnderperform
P/E-6.63
P/S14.30
Revenue$391.78K
Earnings-$574.28K
Dividend yield-
Main Sector
Healthcare

Pharmala Biotech Holdings (MDMA) Total Liabilities

MDMA Total Liabilities in 2022: $757.80K

According to Pharmala Biotech Holdings latest financial reports the total liabilities of MDMA is $757.80K, an increase of 142.82% to 2022. At the end of 2022 company had $312.09K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Pharmala Biotech Holdings is responsible for during its operational activities.

Pharmala Biotech Holdings (MDMA) Total Liabilities History from 2023 to 2022

-
Value:-

MDMA Total Liabilities by year

YearTotal liabilitiesChange
2023$757.80K142.82%
2022$312.09K206.03%
2021$101.98K-

View the Top Total Liabilies Stocks

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org